LTF and Alzheimer disease: In a study, Huperzine A was trapped on targeted PLGA NPs modified with lactoferrin (Lf)-linked N-trimethylated CS (TMC) (HupA Lf-TMC NPs) for nose-to-brain delivery of HupA for AD management.